Alector
Initial Transaction Details
Transaction Date
July 2018
Purpose of Financing
Growth
Stage of Company
Mid Stage
Structure of Financing
Equity
Alector is a privately held biotechnology company whose mission is to develop immuno-neurology and immuno-oncology therapies to treat neurodegenerative diseases and cancer. Alector is headquartered in South San Francisco, Calif.
Website